Recently, we have successfully formulated a new honey and petroleum-based eye ointment, showcasing our commitment to providing effective solutions for eye care.

A clinical study titled “A Clinical Study on the Effect of Ghritkumaryadi Aschyotana (Drops) in the Management of Computer Vision Syndrome,” was conducted to address one of the most common eye complaints in today’s digital world. The study involved 15 patients over a period of 28 days, yielding impressive results:

• Eye strain: 76.21% relief
• Blurred vision: 70.60% relief
• Headaches: 62.51% relief
• Redness: 72.25% relief
• Burning sensation: 64.6% relief
• Dry eyes: 72.25% relief
• Color perception issues: 61.47% improvement
• Slow refocusing: 66.6% improvement
• Excessive fatigue: 60% relief

A clinical study titled “A Clinical Study on the Effect of Nimbadi Aschyotana and Parishek in the Management of Netra Abhishyand (Infective Conjunctivitis)” was conducted on 15 patients over a period of 22 days, showing remarkable results:

• Redness/Congestion: 67% relief
• Burning Sensation: 80.12% relief
• Lacrimation: 47.61% relief
• Foreign Body Sensation: 47.85% relief
• M.P. Discharge: 48.33% relief
• Photophobia: 50.37% relief
• Lid Edema: 75.90% relief
• Itching: 50% relief
• Chemosis: 86% relief

This study demonstrates the significant efficacy of our Nimbadi formulations in treating infective conjunctivitis, with patients experiencing notable relief across a variety of symptom

A clinical study titled “A Clinical Study on the Effect of Rasanjanadi Aschyotan (Eyedrop) in the Management of Netra Abhishyand with Special Reference to Mucopurulent Conjunctivitis” was conducted on 15 patients over a period of 15 days, delivering impressive results:

• Redness/Congestion: 81.82% relief
• Burning Sensation: 77% relief
• Lacrimation: 74.68% relief
• Foreign Body Sensation: 72% relief
• M.P. Discharge: 73% relief
• Photophobia: 79% relief
• Lid Edema: 69.78% relief
• Itching: 74.85% relief
• Chemosis: 69.33% relief

This study highlights the effectiveness of Rasanjanadi Aschyotan in treating mucopurulent conjunctivitis, showing substantial improvement across a range of symptoms.

A clinical study titled “A Clinical Study on the Effect of Ghritkumaryadi Aschyotan (Drops) in the Management of Shudhkakshipaka with Special Reference to Dry Eye Syndrome” was conducted on 20 patients (10 in each group) over a period of 30 days, yielding significant results. The study compared two groups:

• Group A: Ghritkumaryadi Aschyotan (Drops)
• Group B: Ghritkumaryadi Aschyotan (Drops) combined with Glycerin

The results for each group are as follows:

• Redness: 66.67% relief in Group A, 77.78% relief in Group B
• Burning Sensation: 80% relief in Group A, 90% relief in Group B
• Transient Blurring: 83.34% relief in Group A, 87.50% relief in Group B
• Foreign Body Sensation: 92.85% relief in Group A, 100% relief in Group B
• M.P. Discharge: 80% relief in Group A, 85.71% relief in Group B
• Dryness: 85.71% relief in Group A, 90.90% relief in Group B
• Pain: 80% relief in Group A, 85.72% relief in Group B
• Photophobia: 60.01% relief in Group A, 75% relief in Group B
• Itching: 91.60% relief in Group A, 100% relief in Group B
• Crusting: 60% relief in Group A, 75% relief in Group B
• Eyelid Sticking: 66.67% relief in both groups
• Tear Meniscus: 22.22% relief in Group A, 50% relief in Group B
• Mucin Debris: 75% relief in Group A, 80% relief in Group B
• Conjunctival Congestion: 71.42% relief in Group A, 72.72% relief in Group B
• Schirmer-I Test: 15.70% improvement in Group A, 53.34% in Group B
• Tear Break-Up Time (T-BUT): 16.67% improvement in Group A, 46.15% in Group B

This study demonstrates the enhanced effectiveness of combining Ghritkumaryadi Aschyotan with glycerin, particularly in providing greater relief from dry eye symptoms.

A clinical study titled “A Clinical Study on the Effect of Shigruadi Aschyotan (Eye Drop) in the Management of Netra Abhishyand with Special Reference to Allergic Conjunctivitis” was conducted on 20 patients over a period of 15 days, yielding notable results:

• Redness/Congestion: 65.7% relief
• Burning Sensation: 69.69% relief
• Lacrimation: 75% relief
• Foreign Body Sensation: 75.75% relief
• M.P. Discharge: 45% relief
• Photophobia: 72% relief
• Itching: 81% relief
• Heaviness of Lids: 75% relief
• Akshi Shopha (Chemosis): 35% relief

This study highlights the effectiveness of Shigruadi Aschyotan in managing allergic conjunctivitis, offering significant symptom relief in a short duration.